Las células natural killer y su papel en la respuesta inmunitaria durante la infección por el virus de la inmunodeficiencia humana tipo-1

Taborda, Natalia A; Montoya, Carlos J; Rugeles , María T; Hernández , Juan C.
Inmunología (1987) ; 33(1): 11-20, ene.-mar. 2014. ilus
Artículo en Español | IBECS (España) | ID: ibc-125459

Documentos relacionados

  1. HLA/KIR restraint of HIV: surviving the fittest.
  2. Reverse genetics systems for contemporary isolates of respiratory syncytial virus enable rapid evaluation of antibody escape mutants.
  3. Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients.
  4. Prediction of HIV-1 sensitivity to broadly neutralizing antibodies shows a trend towards resistance over time.
  5. Recipient-donor KIR ligand matching prevents CMV reactivation post-haploidentical T cell-replete transplantation.
  6. Evolving Omicron Subvariants Are More Resistant to Antibody Therapy.
  7. HIV-1 adaptation to NK cell-mediated immune pressure.
  8. Immune responses and the emergence of drug-resistant virus strains in vivo.
  9. Viral reservoirs an impediment to HAART: new strategies to eliminate HIV-1.
  10. A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells.